Harpoon Therapeutics, Inc. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/61e0cec6-bada-47b7-aa35-3124882a661d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-67.7M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010030 |
| FY 2021 | $-116.7M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003375 |
| FY 2020 | $-49.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012063 |
| FY 2019 | $-55.6M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010479 |
| FY 2018 | $-4.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-017497 |
| FY 2017 | $-16.8M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007829 |
| FY 2016 | $-11.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-007829 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Harpoon Therapeutics, Inc. — all facts · Revenue · Operating Income